The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 31, 2023

Filed:

May. 03, 2019
Applicant:

Insulet Corporation, Acton, MA (US);

Inventors:

Jason O'Connor, Acton, MA (US);

Joon Bok Lee, Lowell, MA (US);

Trang Ly, Concord, MA (US);

Yibin Zheng, Hartland, WI (US);

Thomas Arnold Peyser, Menlo Park, CA (US);

Jennifer Lena Schneider, Palo Alto, CA (US);

Assignee:

Insulet Corporation, Acton, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G08B 21/04 (2006.01); A61M 5/172 (2006.01); A61B 5/145 (2006.01); A61M 5/142 (2006.01); A61M 5/145 (2006.01); A61B 5/00 (2006.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); A61B 5/14532 (2013.01); A61M 5/145 (2013.01); A61M 5/14244 (2013.01); A61B 5/486 (2013.01); A61B 5/6832 (2013.01); A61M 2005/14208 (2013.01); A61M 2005/14252 (2013.01); A61M 2205/18 (2013.01); A61M 2205/52 (2013.01); A61M 2230/201 (2013.01);
Abstract

Disclosed are a system, methods and computer-readable medium products that provide safety constraints for an insulin-delivery management program. Various examples provide safety constraints for a control algorithm-based drug delivery system that provides automatic delivery of a drug based on sensor input. Glucose measurement values may be received at regular time intervals from a sensor. A processor may predict future glucose values based on prior glucose measurement values. The safety constraints assist in safe operation of the drug delivery system during various operational scenarios. In some examples, predicted future glucose values may be used to implement safety constraints that mitigate under-delivery or over-delivery of the drug while not overly burdening the user of the drug delivery system and without sacrificing performance of the drug delivery system. Other safety constraints are also disclosed.


Find Patent Forward Citations

Loading…